文献速递妇科

CDKN2B-AS1通过miR-424-5p调控AKT3影响卵巢子宫内膜异位症细胞行为

Effects of CDKN2B-AS1 on cellular proliferation, invasion and AKT3 expression are attenuated by miR-424-5p in a model of ovarian endometriosis.
PubMed 文献 · Reprod Biomed Online · 2021-02-12

本研究探讨长链非编码RNA CDKN2B-AS1在卵巢子宫内膜异位症中的作用机制。结果显示CDKN2B-AS1在在位和异位内膜中表达上调,过表达可促进子宫内膜基质细胞和Ishikawa细胞增殖、侵袭及上皮-间质转化,而miR-424-5p过表达可减弱这些效应。机制上CDKN2B-AS1作为ceRNA吸附miR-424-5p并靶向AKT3,提示其可能成为卵巢子宫内膜异位症的治疗靶点。

要点

  • CDKN2B-AS1在卵巢子宫内膜异位症在位和异位内膜中表达上调。
  • CDKN2B-AS1过表达促进子宫内膜细胞增殖、侵袭和上皮-间质转化。
  • CDKN2B-AS1通过吸附miR-424-5p上调AKT3发挥ceRNA作用。

核心结论

  • CDKN2B-AS1在卵巢子宫内膜异位症中通过ceRNA机制吸附miR-424-5p并靶向AKT3,促进细胞增殖和侵袭,可能成为潜在治疗靶点。

研究设计与样本

  • 采用CCK8、transwell和EdU实验评估细胞增殖、侵袭和DNA合成能力。
  • 用Western blot检测上皮-间质转化标志物和AKT三种亚型的蛋白表达。
  • 用实时PCR检测CDKN2B-AS1和候选miRNA在异位、在位和正常子宫内膜组织中的相对表达水平。
  • 用荧光素酶报告基因实验确定CDKN2B-AS1与miRNA及miR-424-5p与AKT3的靶向关系。

主要发现

  • CDKN2B-AS1在在位和异位子宫内膜中相对表达水平上调。
  • 在子宫内膜基质细胞和Ishikawa细胞中,CDKN2B-AS1过表达促进细胞增殖和侵袭,增加波形蛋白表达并降低E-钙黏蛋白表达。
  • 生物信息学工具和荧光素酶报告基因实验证实miR-424-5p是CDKN2B-AS1的靶标。
  • miR-424-5p过表达显著减弱CDKN2B-AS1过表达增强的细胞表型。
  • 荧光素酶报告基因实验显示miR-424-5p可直接靶向AKT3。

临床怎么用

  • CDKN2B-AS1/miR-424-5p/AKT3轴可能作为卵巢子宫内膜异位症的未来治疗靶点,但尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Endometriosis is a common and complicated gynaecologic disease. Long non-coding RNA CDKN2B-AS1 plays a crucial role in the development and progression of several cancers. Whether CDKN2B-AS1 contributes to endometriosis, however, remains unknown. DESIGN: Cellular proliferation, invasion and DNA synthesis abilities were assessed by CCK8, transwell and 5-ethynyle-2'-deoxyuridine assays. The expression of epithelial-mesenchymal transition markers and three isoforms of AKT was detected using Western blot. Real-time polymerase chain reaction was used to determine the relative expression levels of CDKN2B-AS1 and candidate miRNAs in ectopic, eutopic endometria and normal endometrial tissues. The relationship between CDKN2B-AS1 and miRNA was determined by luciferase reporter assays. RESULTS: The relative expression level of CDKN2B-AS1 was up-regulated in eutopic and ectopic endometria. In endometrial stromal cells and Ishikawa cells, CDKN2B-AS1 overexpression promoted cellular proliferation and invasion, and increased the protein expression of vimentin but decreased the expression of E-cadherin. miR-424-5p was confirmed the target of CDKN2B-AS1 through bioinformatics tools and luciferase reporter assays. In addition, the enhanced effect of cellular phenotype of CDKN2B-AS1 overexpression was significantly attenuated by miR-424-5p overexpression. Furthermore, miR-424-5p was able to directly target AKT3 through luciferase reporter assay. Mechanistically, CDKN2B-AS1 acts as a ceRNA by sponging miR-424-5p and targets AKT3. CONCLUSIONS: The cellular mechanism of CDKN2B-AS1 in endometriosis was confirmed; CDKN2B-AS1 may be a potential target for ovarian endometriosis therapy.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Wang S, Yi M, Zhang X, et al. Effects of CDKN2B-AS1 on cellular proliferation, invasion and AKT3 expression are attenuated by miR-424-5p in a model of ovarian endometriosis. Reprod Biomed Online. 2021. PMID: 33820740. doi:10.1016/j.rbmo.2021.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。